CF PharmTech, Inc. — Investor Relations & Filings
Filings indexed
83
across all filing types
Latest filing
2026-05-08
Regulatory Filings
Country
HK
Hong Kong
Listing
HKEX
2652
CF PharmTech, Inc. is a commercial-stage specialty pharmaceutical company specializing in the research, development, manufacturing, and commercialization of complex drug delivery systems, primarily focusing on inhalation technologies. The company develops treatments for major respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), and allergic rhinitis. Its core product platforms encompass Inhalation Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), inhalation liquid preparations (nebulizers), and nasal sprays. The firm also leverages advanced formulation techniques, such as liposomes, to enhance drug efficacy and delivery.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NEXT DAY DISCLOSURE RETURN | 2026-05-08 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-07 | English | |
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 | 2026-05-07 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | |
| 2025 Environmental, Social and Governance Report | 2026-04-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44205477 | NEXT DAY DISCLOSURE RETURN | 2026-05-08 | English | ||
| 42895590 | NEXT DAY DISCLOSURE RETURN | 2026-05-07 | English | ||
| 42657623 | Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 | 2026-05-07 | English | ||
| 41372493 | NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | ||
| 40869494 | NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | ||
| 39090420 | 2025 Environmental, Social and Governance Report | 2026-04-30 | English | ||
| 39083797 | 2025 Annual Report | 2026-04-30 | English | ||
| 39062062 | NEXT DAY DISCLOSURE RETURN | 2026-04-30 | English | ||
| 37991777 | NEXT DAY DISCLOSURE RETURN | 2026-04-28 | English | ||
| 37399646 | NEXT DAY DISCLOSURE RETURN | 2026-04-27 | English | ||
| 36145217 | NEXT DAY DISCLOSURE RETURN | 2026-04-24 | English | ||
| 35737075 | NEXT DAY DISCLOSURE RETURN | 2026-04-23 | English | ||
| 35229316 | NEXT DAY DISCLOSURE RETURN | 2026-04-22 | English | ||
| 34743258 | NEXT DAY DISCLOSURE RETURN | 2026-04-21 | English | ||
| 34691867 | NEXT DAY DISCLOSURE RETURN | 2026-04-20 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bloomage Biotechnology Corporation Limited
Global leader in hyaluronic acid and bioactive substance re…
|
688363 | CN | Manufacturing |
|
BL Pharmtech Corp.
Researches, develops, and sells health foods, supplements, …
|
065170 | KR | Manufacturing |
|
Blueberries Medical Corp.
Licensed producer of science-based wellness products derive…
|
BBM | CA | Manufacturing |
|
Blue Jet Healthcare Limited
CDMO specializing in contrast media intermediates, sweetene…
|
BLUEJET | IN | Manufacturing |
|
BNC Korea Co, Ltd
Develops hyaluronic acid-based dermal fillers and botulinum…
|
256840 | KR | Manufacturing |
|
Boditech Med Inc.
Develops, manufactures, and distributes in-vitro diagnostic…
|
206640 | KR | Manufacturing |
|
BOIRON
A family-owned pharmaceutical laboratory and a world leader…
|
BOI | FR | Manufacturing |
|
BOLAK CO.,LTD
Manufactures specialty ingredients for the food, pharmaceut…
|
002760 | KR | Manufacturing |
|
Bolt Biotherapeutics, Inc.
Clinical-stage biotech developing immuno-oncology therapies…
|
BOLT | US | Manufacturing |
|
Bone Biologics Corp
Develops a protein-based bone graft substitute for spinal f…
|
BBLG | US | Manufacturing |
CF PharmTech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/50735/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=50735 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=50735 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=50735 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 50735}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CF PharmTech, Inc. (id: 50735)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.